552 related articles for article (PubMed ID: 9421697)
1. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.
Spencer CM; Goa KL; Gillis JC
Drugs; 1997 Dec; 54(6):925-75. PubMed ID: 9421697
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
Plosker GL; Foster RH
Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus: a further update of its use in the management of organ transplantation.
Scott LJ; McKeage K; Keam SJ; Plosker GL
Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.
Peters DH; Fitton A; Plosker GL; Faulds D
Drugs; 1993 Oct; 46(4):746-94. PubMed ID: 7506654
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
Dunn CJ; Wagstaff AJ; Perry CM; Plosker GL; Goa KL
Drugs; 2001; 61(13):1957-2016. PubMed ID: 11708766
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitors in renal transplantation: what is the best option?
Tanabe K
Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
[TBL] [Abstract][Full Text] [Related]
8. A risk-benefit assessment of tacrolimus in transplantation.
Winkler M; Christians U
Drug Saf; 1995 May; 12(5):348-57. PubMed ID: 7545405
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive drugs in paediatric liver transplantation.
van Mourik ID; Kelly DA
Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
Saudek F; Malaise J; Boucek P; Adamec M;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant diabetes mellitus. The role of immunosuppression.
Jindal RM; Sidner RA; Milgrom ML
Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors in pediatric renal transplant recipients.
Filler G
Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
14. Tailoring tacrolimus-based immunotherapy in renal transplantation.
Yang HC
Nephrol Dial Transplant; 2003 May; 18 Suppl 1():i16-20. PubMed ID: 12738759
[TBL] [Abstract][Full Text] [Related]
15. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[TBL] [Abstract][Full Text] [Related]
16. Status of liver and gastrointestinal transplantation at the University of Miami.
Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG
Clin Transpl; 1996; ():187-201. PubMed ID: 9286568
[TBL] [Abstract][Full Text] [Related]
17. [Clinical pharmacokinetics and therapeutic monitoring of tacrolimus].
Garraffo R
Therapie; 1997; 52(4):345-52. PubMed ID: 9437890
[TBL] [Abstract][Full Text] [Related]
18. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.
U.S. Multicenter FK506 Liver Study Group
N Engl J Med; 1994 Oct; 331(17):1110-5. PubMed ID: 7523946
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus: a new immunosuppressive agent.
Kelly PA; Burckart GJ; Venkataramanan R
Am J Health Syst Pharm; 1995 Jul; 52(14):1521-35. PubMed ID: 7552894
[TBL] [Abstract][Full Text] [Related]
20. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
